However, the mTOR inhibitor temsirolimus failed to prolong OS when associated with radiotherapy versus radiotherapy plus temozolomide in patients with newly diagnosed unmethylated O6-methylguanine-O-methyl-transferase (MGMT) GBM. This evidence concerns the gene MGMT and glioblastoma.